Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
Our results demonstrate the potent immunosuppressive activity of combination MM and BQR therapy to prolong allograft survival. In addition, MM may provide a highly effective therapy for the prevention of chronic rejection.